Me-RIP experimental results explained that the increase of m6A modification of TK1 in ESCC tissues may account for such expressional upregulation (26), and the PAR-CLIP test revealed that IGF2BP2 recognized m6A modification of TK1 mRNA to maintain its stability. This evidence concerns the gene TK1 and esophageal squamous cell carcinoma.